Venetoclax-Azacitidine Versus Azacitidine for the Treatment of Primary Refractory or First Relapsed Acute Myeloid Leukemia. An IPC-DATAML-MSKCC Retrospective Study
- PMID: 40088036
- DOI: 10.1002/ajh.27626
Venetoclax-Azacitidine Versus Azacitidine for the Treatment of Primary Refractory or First Relapsed Acute Myeloid Leukemia. An IPC-DATAML-MSKCC Retrospective Study
Keywords: azacitidine; leukemia; relapsed/refractory AML; venetoclax.
Publication types
LinkOut - more resources
Full Text Sources
